# Orthobiologics Phoenix Means Blood-Based Joint Care *Orthobiologics Phoenix | blood-based care for soreness* > Orthobiologics Phoenix means blood-based office care for joint soreness, along with non-surgical choices and a local QC Kinetix visit. **Help for joint soreness** Orthobiologics Phoenix: blood-based care for sore joints Learn what may be causing the ache and what care may help. - Soreness explained - Treatment facts - Local clinic **Evidence-room referral** ## For orthobiologics in Phoenix, we recommend QC Kinetix West-Phoenix readers can take this site's evidence questions to the Banner Estrella office at 9305 W. Thomas Rd., Suite 460. QC Kinetix offers consultations and provides regenerative treatment options there, with the visit serving as the place to match a person—not a headline—to the available choices. - 9305 W. Thomas Rd., Suite 460, Phoenix, AZ 85037 - Free consultation - (602) 837-PAIN Book a free consultation: Joint soreness often comes from long use, and this page covers what may help. Your knee, hip, or shoulder may feel stiff and achy. Extra walking, stairs, kneeling, or a hard workday may stir it up. I'd write when it begins, what worsens it, and what brings relief. ## When the soreness happens helps explain what is wrong An ache during movement isn't the same as soreness that wakes you. Swelling, warmth, stiffness, weakness, or locking also matter during an exam. Tell the health provider when it began and which motions start it. Also say how long it stays and whether the joint swells, locks, or weakens. Because soreness can change through the day, notes from home often give the health provider a clearer account than memory alone can offer during a short office visit later. You won't have to recall everything while sitting in the exam room. The exam may lead to home care, another test, or a surgery talk. One answer won't fit every joint or every health history. ## QC Kinetix begins with your soreness and an exam QC Kinetix offers regenerative treatments, meaning office shots prepared from your own blood. The name doesn't mean that worn tissue grows back. Its medical providers are the health staff who examine your joint. They'll explain non-surgical choices and what each visit involves. The aim is possible relief and better daily use, but results aren't certain. You'll talk about past care and the movements you miss. Ask how the blood is prepared, where it goes, and what it may do. Cost, time, and follow-up also belong in that talk. Joint preservation means trying to keep your joint working while you weigh surgery. Home exercise may still fit, and surgery may still deserve a fair talk. ## The Banner Estrella office is on Phoenix's west side Banner Estrella is a nearby office for discussing joint soreness that hasn't settled. The staff can explain the exam, care choices, cost, and follow-up time. Take your medicine list, past test results, and notes about painful tasks. You'll keep the visit focused on what you need from the joint. QC Kinetix offers consultations at 9305 W. Thomas Rd., Suite 460, Phoenix, AZ 85037. Call (602) 837-PAIN before traveling to confirm appointment details. - Nearest QC Kinetix location: QC Kinetix (Banner Estrella), 9305 W. Thomas Rd., Suite 460, Phoenix, AZ 85037 - Phone: (602) 837-PAIN / (602) 837-7246 ## Sources 1. A network meta-analysis restricted to LARGE randomized trials (at least 100 patients per group; 57 RCTs, 22,795 participants, 18 intra-articular interventions) found treatment effects were consistently larger in the 35 high-risk-of-bias trials than in the 22 low/unclear-risk trials. In the main analysis excluding high-risk trials, triamcinolone had the highest probability of exceeding the minimal important difference at weeks 2 and 6; hyaluronic acid had no effect on pain (SMD -0.04, 95% CrI -0.19 to 0.11, 11 trials) but higher odds of dropouts due to adverse events (OR 2.01) and of serious adverse events (OR 1.86). The effects of 16 of the 18 interventions were smaller than the MID and most were consistent with placebo effects. Pereira TV, et al. — [Effectiveness and safety of intra-articular interventions for knee and hip osteoarthritis based on large randomized trials: A systematic review and network meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/39265924/). *Osteoarthritis and Cartilage*, 2025. DOI: 10.1016/j.joca.2024.08.014. 2. A Bayesian network meta-analysis of 48 Level I-II randomized trials (9,338 knees) with a minimum 6-month follow-up ranked the four commonest intra-articular injections. HA and PRP both significantly improved pain versus placebo; HA, PRP and BMAC all significantly improved function versus placebo. SUCRA rankings were PRP 91.54, BMAC 76.46, HA 53.12, corticosteroid 15.18 and placebo 13.70 - corticosteroid ranked barely above placebo at six months and beyond. Jawanda H, et al. — [Platelet-Rich Plasma, Bone Marrow Aspirate Concentrate, and Hyaluronic Acid Injections Outperform Corticosteroids in Pain and Function Scores at a Minimum of 6 Months as Intra-Articular Injections for Knee Osteoarthritis: A Systematic Review and Network Meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/38331363/). *Arthroscopy*, 2024. DOI: 10.1016/j.arthro.2024.01.037. 3. A network meta-analysis of 43 trials (5,554 patients) reached the OPPOSITE ranking to the more recent orthobiologic-favourable reviews: steroids ranked most likely to be effective for pain and function, with adipose MSC and multiple PRP ranked LEAST likely; single PRP, multiple PRP and adipose MSC did not produce a relevant reduction in pain or improvement in function versus placebo. The authors noted treatment-effect differences were small and potentially not clinically meaningful either way. Han SB, et al. — [Intra-Articular Injections of Hyaluronic Acid or Steroids Associated With Better Outcomes Than Platelet-Rich Plasma, Adipose Mesenchymal Stromal Cells, or Placebo in Knee Osteoarthritis: A Network Meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/32305424/). *Arthroscopy*, 2021. DOI: 10.1016/j.arthro.2020.03.041. 4. RESTORE, the largest and most rigorously blinded placebo-controlled PRP trial in knee OA (n=288, participant-, injector- and assessor-blinded), gave three weekly injections of a commercial leukocyte-poor PRP or saline. At 12 months the change in knee pain was -2.1 vs -1.8 points (difference -0.4; 95% CI -0.9 to 0.2; P=.17) and the change in medial tibial cartilage volume was -1.4% vs -1.2% (difference -0.2%; P=.81). Twenty-nine of 31 prespecified secondary outcomes showed no between-group difference. The authors concluded the findings do not support the use of PRP for knee OA. Bennell KL, et al. — [Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial.](https://pubmed.ncbi.nlm.nih.gov/34812863/). *JAMA*, 2021. DOI: 10.1001/jama.2021.19415. 5. The largest head-to-head trial of cell-based orthobiologics to date randomised 480 patients with KL II-IV knee OA across four arms: autologous bone marrow aspirate concentrate, autologous adipose stromal vascular fraction, allogeneic umbilical cord tissue-derived MSCs, and a corticosteroid injection control. At 12 months NONE of the three orthobiologic injections was superior to another or to the corticosteroid control on either co-primary endpoint (VAS pain, KOOS pain), and none of the four groups showed a significant change in MRI osteoarthritis score from baseline. No procedure-related serious adverse events were reported. Mautner K, et al. — [Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial.](https://pubmed.ncbi.nlm.nih.gov/37919438/). *Nature Medicine*, 2023. DOI: 10.1038/s41591-023-02632-w. 6. FDA states verbatim of stem cell products, stromal vascular fraction (adipose-derived cells), umbilical cord blood, Wharton's jelly, amniotic fluid and exosome products: 'None of these products have been approved for the treatment of any orthopedic condition, such as osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain, or shoulder pain.' The only FDA-approved stem cell products in the United States are blood-forming (hematopoietic progenitor) cells derived from umbilical cord blood, approved only for disorders of blood production, and there are currently NO FDA-approved exosome products. U.S. Food and Drug Administration — [Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes](https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/consumer-alert-regenerative-medicine-products-including-stem-cells-and-exosomes). *FDA (Center for Biologics Evaluation and Research)*, 2020. ## Get the exam, cost, and timing explained before choosing Take your questions about the exam, price, time, and follow-up to Banner Estrella. QC Kinetix can discuss non-surgical choices that may fit your joint and health history. Book a free consultation: --- Know what the care involves before you choose. Orthobiologics Phoenix explained as blood-based care, with help for soreness, visit questions, cost, and local care. Plain answers about joint soreness, blood-based care choices, costs, and a local visit for Phoenix readers. This site is operated by the owners of the QC Kinetix Phoenix-area clinics, including the Banner Estrella office recommended here, so it is first-party educational publishing from a business that benefits when readers book. © 2026 Phoenix Orthobiologics Studio. General education, not medical advice for an individual joint.